Low-dose corticomedullary phase CT urography with artificial intelligence iterative reconstruction for bladder cancer evaluation
British Journal of Radiology · 2026
DOI: 10.1093/bjr/tqaf315 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Radiology, 2026. Verfasst von Haifeng Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Wuhan No.1 Hospital, Wuhan, Hubei 430022, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Tomography, X-Ray Computed, Urography, Artificial Intelligence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
To test the feasibility and quantify the performance of low-dose CT urography (CTU) with artificial intelligence iterative reconstruction (AIIR) for bladder cancer (BC) evaluation.
Methods
A total of 122 patients undergoing CTU examination were prospectively enrolled, where the routine-dose scan (120 kVp, ref 100 mAs) at corticomedullary phase (CMP) was followed immediately by a low-dose scan (120 kVp, ref 20 mAs). Routine-dose images were reconstructed with hybrid iterative reconstruction (HIR, RD-HIR), while low-dose images were with AIIR (LD-AIIR) and HIR (LD-HIR). The image quality was first evaluated regarding streak artefacts around the bladder and then in contrast-to-noise ratio (CNR) for various manifestations of bladder wall. The diagnostic performance of BC was characterized using receiver operating characteristic (ROC) analysis, in respect to the clinical diagnostic report.
Results
The effective dose at low-dose CMP was 80.2% lower than routine-dose scan (7.6 ± 1.2 vs 1.5 ± 0.3 mSv). Nineteen cases in LD-HIR were deemed clinically unacceptable for presenting severe artefacts around the bladder, while found well above the basic requirement in LD-AIIR. The highest CNR was found in LD-AIIR in all scenarios (all P < .001). The area under ROC curve in LD-AIIR was comparable to RD-HIR (0.988 vs 0.990, P = .172) and significantly higher than LD-HIR (0.988 vs 0.831, P < .001).
Conclusions
The low-dose AIIR protocol allows for a profound dose reduction (80.2%) while maintaining reliable diagnosis of BC on corticomedullary phase CTU images. Advances in knowledge Corticomedullary phase CTU with AIIR permits 80.2% dose reduction while preserving reliable BC diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Wuhan No.1 Hospital, Wuhan, Hubei 430022, China.
- School of Laboratory Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, China.
- United Imaging Healthcare, Shanghai 201800, China.
- Department of Urology, Wuhan No.1 Hospital, Wuhan, Hubei 430022, China.
ORCID-Profile: Haifeng Liu, Xinrui Jiang, Tiantian Wang, Guozhi Zhang, Ming Zhao, Hongfen Peng
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, H., Jiang, X., Wang, T., Zhang, G., Zhao, M., Xiang, W., & Peng, H. (2026). Low-dose corticomedullary phase CT urography with artificial intelligence iterative reconstruction for bladder cancer evaluation. British Journal of Radiology. https://doi.org/10.1093/bjr/tqaf315
Vancouver
Liu H, Jiang X, Wang T, Zhang G, Zhao M, Xiang W, et al. Low-dose corticomedullary phase CT urography with artificial intelligence iterative reconstruction for bladder cancer evaluation. British Journal of Radiology. 2026. doi:10.1093/bjr/tqaf315
BibTeX
@article{Liu2026,
author = {Liu, Haifeng and Jiang, Xinrui and Wang, Tiantian and Zhang, Guozhi and Zhao, Ming and Xiang, Wei and Peng, Hongfen},
title = {Low-dose corticomedullary phase CT urography with artificial intelligence iterative reconstruction for bladder cancer evaluation},
journal = {British Journal of Radiology},
year = {2026},
doi = {10.1093/bjr/tqaf315}
}
EUVIMED